These results suggest that DNMT1 heterozygous knockdown was associated with the suppression of DNMT enzyme activity which may underlie temsirolimus resistance in ccRCC cell line tumors. The gene discussed is DNMT1; the disease is nonpapillary renal cell carcinoma.